Post by Deleted on Mar 5, 2019 22:30:50 GMT
Popular FDA commish Scott Gottlieb has handed in his resignation
In a stunning turn of events, FDA commissioner Scott Gottlieb is resigning from his post and leaving office in a matter of weeks.
The Washington Post reported that Gottlieb, who’s been commuting from Connecticut, told administration officials that he wants to spend more time with his family.
Gottlieb arrived at the FDA shortly after the Trump administration took office, vowing to both uphold the gold standard in drug development while doing everything possible to facilitate drug makers’ work — at least for the legitimate players.
He has been enormously popular in his short stint, with the vast majority of execs acclaiming his work at the agency. He’s also been popular with President Donald Trump, finding a secure spot for himself in an administration noted for rapid turnover.
So what happened here?
Just weeks ago Gottlieb insisted on Twitter that rumors of his pending departure from the agency were flat wrong. He tweeted:
We’ve got a lot important policy we’ll advance this year. I look forward to sharing my 2019 strategic roadmap soon.
The big question now is who will replace him. Trump freaked out many execs by entertaining Peter Thiel’s push for a libertarian approach, which would have erased many of the barriers to introducing new drugs — along with the credibility that goes with an FDA sanction.
“He has been an exemplary public health leader, aggressive advocate for American patients, and passionate promoter of innovation,” Health and Human Services Secretary Alex Azar said in a statement. “I will personally miss working with Scott on the important goals we share, and I know that is true for so many other members of the HHS family. …The public health of our country is better off for the work Scott and the entire FDA team have done over the last two years.”
===============================
C L
In a stunning turn of events, FDA commissioner Scott Gottlieb is resigning from his post and leaving office in a matter of weeks.
The Washington Post reported that Gottlieb, who’s been commuting from Connecticut, told administration officials that he wants to spend more time with his family.
Gottlieb arrived at the FDA shortly after the Trump administration took office, vowing to both uphold the gold standard in drug development while doing everything possible to facilitate drug makers’ work — at least for the legitimate players.
He has been enormously popular in his short stint, with the vast majority of execs acclaiming his work at the agency. He’s also been popular with President Donald Trump, finding a secure spot for himself in an administration noted for rapid turnover.
So what happened here?
Just weeks ago Gottlieb insisted on Twitter that rumors of his pending departure from the agency were flat wrong. He tweeted:
We’ve got a lot important policy we’ll advance this year. I look forward to sharing my 2019 strategic roadmap soon.
The big question now is who will replace him. Trump freaked out many execs by entertaining Peter Thiel’s push for a libertarian approach, which would have erased many of the barriers to introducing new drugs — along with the credibility that goes with an FDA sanction.
“He has been an exemplary public health leader, aggressive advocate for American patients, and passionate promoter of innovation,” Health and Human Services Secretary Alex Azar said in a statement. “I will personally miss working with Scott on the important goals we share, and I know that is true for so many other members of the HHS family. …The public health of our country is better off for the work Scott and the entire FDA team have done over the last two years.”
===============================
C L
